Figure 1 — A differentially-methylated-region signature predicts the recurrence risk for patients with early stage lung adenocarcinoma

Research Paper|Volume 16, Issue 21|pp. 13323–13339

A differentially-methylated-region signature predicts the recurrence risk for patients with early stage lung adenocarcinoma

Back to articleFigure 1(1 of 4)

100%

Figure 1.Work flow of the study. Abbreviations: LUAD: lung adenocarcinoma; DMR: differentially methylated region; LASSO: least absolute shrinkage and selection operator.